Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| fibroblast | 41 studies | 48% ± 21% | |
| smooth muscle cell | 31 studies | 45% ± 18% | |
| pericyte | 26 studies | 35% ± 15% | |
| endothelial cell of lymphatic vessel | 18 studies | 31% ± 12% | |
| endothelial cell | 15 studies | 24% ± 11% | |
| myofibroblast cell | 15 studies | 61% ± 21% | |
| connective tissue cell | 14 studies | 49% ± 19% | |
| mesothelial cell | 10 studies | 34% ± 19% | |
| adipocyte | 10 studies | 46% ± 15% | |
| platelet | 8 studies | 31% ± 9% | |
| capillary endothelial cell | 8 studies | 26% ± 8% | |
| GABAergic neuron | 7 studies | 35% ± 20% | |
| glutamatergic neuron | 7 studies | 42% ± 29% | |
| neuron | 6 studies | 28% ± 16% | |
| oligodendrocyte precursor cell | 6 studies | 32% ± 12% | |
| astrocyte | 5 studies | 29% ± 10% | |
| adventitial cell | 5 studies | 45% ± 24% | |
| alveolar macrophage | 5 studies | 26% ± 5% | |
| cardiac muscle cell | 5 studies | 44% ± 6% | |
| endothelial cell of vascular tree | 5 studies | 20% ± 6% | |
| interneuron | 5 studies | 34% ± 19% | |
| hematopoietic stem cell | 5 studies | 34% ± 10% | |
| retina horizontal cell | 4 studies | 34% ± 11% | |
| Mueller cell | 4 studies | 38% ± 13% | |
| muscle cell | 4 studies | 53% ± 22% | |
| abnormal cell | 3 studies | 29% ± 13% | |
| amacrine cell | 3 studies | 40% ± 14% | |
| endothelial cell of artery | 3 studies | 20% ± 3% | |
| type I pneumocyte | 3 studies | 30% ± 14% | |
| mast cell | 3 studies | 19% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 71% | 34173.39 | 173 / 245 | 87% | 92.13 | 438 / 502 |
| thymus | 78% | 23254.73 | 510 / 653 | 76% | 113.34 | 458 / 605 |
| brain | 25% | 4765.73 | 669 / 2642 | 99% | 257.80 | 701 / 705 |
| uterus | 91% | 43983.48 | 154 / 170 | 28% | 45.57 | 129 / 459 |
| lung | 89% | 31456.50 | 513 / 578 | 26% | 20.26 | 298 / 1155 |
| breast | 81% | 46057.86 | 372 / 459 | 32% | 17.99 | 362 / 1118 |
| bladder | 86% | 54323.95 | 18 / 21 | 20% | 15.27 | 103 / 504 |
| esophagus | 70% | 76291.17 | 1007 / 1445 | 33% | 20.48 | 60 / 183 |
| muscle | 100% | 380543.28 | 803 / 803 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 126759.35 | 1332 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 99% | 72059.43 | 1186 / 1204 | 0% | 0 | 0 / 0 |
| intestine | 78% | 49652.97 | 757 / 966 | 19% | 11.65 | 100 / 527 |
| kidney | 2% | 347.38 | 2 / 89 | 85% | 277.99 | 766 / 901 |
| heart | 87% | 60885.97 | 747 / 861 | 0% | 0 | 0 / 0 |
| stomach | 48% | 34424.76 | 171 / 359 | 30% | 35.04 | 86 / 286 |
| adrenal gland | 0% | 85.89 | 1 / 258 | 67% | 45.30 | 153 / 230 |
| ovary | 15% | 4853.43 | 27 / 180 | 33% | 16.98 | 144 / 430 |
| pancreas | 0% | 0 | 0 / 328 | 38% | 21.88 | 68 / 178 |
| skin | 15% | 3275.88 | 274 / 1809 | 22% | 9.47 | 104 / 472 |
| eye | 0% | 0 | 0 / 0 | 28% | 8.41 | 22 / 80 |
| tonsil | 0% | 0 | 0 / 0 | 24% | 15.32 | 11 / 45 |
| liver | 0% | 0 | 0 / 226 | 8% | 2.91 | 31 / 406 |
| spleen | 1% | 141.54 | 2 / 241 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 69.05 | 3 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_2000134 | Biological process | negative regulation of G1/S transition of mitotic cell cycle |
| GO_0010972 | Biological process | negative regulation of G2/M transition of mitotic cell cycle |
| GO_0043268 | Biological process | positive regulation of potassium ion transport |
| GO_1901016 | Biological process | regulation of potassium ion transmembrane transporter activity |
| GO_0030154 | Biological process | cell differentiation |
| GO_0009887 | Biological process | animal organ morphogenesis |
| GO_0007517 | Biological process | muscle organ development |
| GO_0003254 | Biological process | regulation of membrane depolarization |
| GO_0030308 | Biological process | negative regulation of cell growth |
| GO_0005829 | Cellular component | cytosol |
| GO_0005925 | Cellular component | focal adhesion |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0005515 | Molecular function | protein binding |
| GO_0003674 | Molecular function | molecular_function |
| GO_0046872 | Molecular function | metal ion binding |
| GO_0044325 | Molecular function | transmembrane transporter binding |
| Gene name | FHL1 |
| Protein name | Four and a half LIM domains 1 Four and a half LIM domains protein 1 (FHL-1) (Skeletal muscle LIM-protein 1) (SLIM) (SLIM-1) |
| Synonyms | SLIM1 |
| Description | FUNCTION: May have an involvement in muscle development or hypertrophy. |
| Accessions | A0A0D9SEY7 A0A0D9SFB0 ENST00000651929.2 [Q13642-1] ENST00000394155.8 [Q13642-2] Q5JXH8 ENST00000370676.7 ENST00000452016.5 ENST00000628919.3 [Q13642-1] ENST00000627578.2 Q13642 ENST00000434885.5 A0A494C1G1 Q5JXH7 Q5JXI0 ENST00000625935.2 ENST00000628443.2 ENST00000535737.5 [Q13642-1] ENST00000543669.5 [Q13642-1] ENST00000370674.3 ENST00000652745.1 ENST00000627383.2 ENST00000627812.2 A0A494C0J3 ENST00000449474.5 ENST00000630278.2 Q5JXI3 A0A0D9SGD1 ENST00000458357.5 Q5JXI8 A0A0D9SFZ9 ENST00000652457.1 ENST00000539015.5 [Q13642-4] ENST00000456445.5 Q5JXH9 ENST00000420362.5 A0A0D9SGC5 ENST00000630084.2 [Q13642-1] ENST00000628032.2 ENST00000618438.4 [Q13642-3] A0A0D9SFI6 Q5JXI2 ENST00000629039.2 [Q13642-1] A0A0D9SGB2 ENST00000651256.1 A0A494C0D6 ENST00000628568.1 [Q13642-1] ENST00000370683.6 [Q13642-5] ENST00000394153.6 [Q13642-1] ENST00000651089.1 [Q13642-2] |